Top

Molecular Templates Investors 3

3

SEC Filing Details

Document Details

Form

Filing Date

Aug 10, 2017

Document Date

Jul 31, 2017

Form Description

Initial filing by director officer or owner of more than ten percent.

Filing Group

3,4,5

Company

Molecular Templates

Issuer

THRESHOLD PHARMACEUTICALS INC

Filing Formats

View HTML

Date	Title and Summary
Toggle SummaryAugust 9, 2018	Molecular Templates, Inc. Reports Second Quarter 2018 Financial Results AUSTIN, Texas , Aug. 09, 2018 (GLOBE NEWSWIRE) -- Molecular Templates , Inc. (Nasdaq:MTEM, “Molecular” or “Molecular Templates”), a clinical-stage oncology company focused on the discovery and development of the company’s proprietary engineered toxin bodies (ETBs), which are differentiated,
Toggle SummaryJune 21, 2018	Molecular Templates Set to Join the Russell 3000® and Russell Microcap® Indexes AUSTIN, Texas , June 21, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. , (Nasdaq:MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies, a new class of targeted biologic therapies that possess unique mechanisms of action in